Lifecore Biomedical, Inc. LFCR Reportable Segment — Net Income (Loss) Attributable to Parent
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — net income (loss) attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s reportable segment — net income (loss) attributable to parent?
- Lifecore Biomedical, Inc. (LFCR) reported reportable segment — net income (loss) attributable to parent of -$14.98M in Q1 2026.
- What does reportable segment — net income (loss) attributable to parent mean?
- This metric serves as the primary indicator of the business segment's bottom-line profitability after accounting for all operating expenses, interest, taxes, and non-controlling interests. It measures the residual value generated by the segment that accrues to the parent company's shareholders. Tracking this metric is critical for evaluating the segment's overall economic viability and its contribution to the consolidated financial health of the organization.